Get notified when TNXP files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TNXP Tonix Pharmaceuticals Holding Corp. 8-K

Tonix Pharmaceuticals reports Q1 2026 operating results

Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read

Key Changes

  • medium

    Company announced operating results for the quarter ended March 31, 2026, via press release. Specific financial metrics and performance details are contained in the attached exhibit.

    Item 2.02 verify on EDGAR →
  • low

    This is a routine quarterly earnings disclosure filed under Item 2.02 of Form 8-K. The filing body contains no substantive financial details beyond referencing the press release.

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.

Partner

Trade TNXP commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify